NVO Earnings

NVO reported its earnings on 2026-02-04, showcasing a revenue of 12.34B against an estimate of 11.96B, resulting in a 3.15% surprise. The EPS was 1, surpassing the expected 0.9 by 11.11%. The stock experienced a -6.18% price change on the earnings day and a -1.85% change over the next five days, reflecting market reactions to the results.

Following NVO's earnings announcement on 2026-02-04, the stock price moved by -6.18% on the day of the release. Over the subsequent five days, it saw a -1.85% change. Historically, NVO's stock price tends to shift by an average of 6% in the 10 days leading up to earnings and 5.13% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate NVO's annual revenue to reach 76.16B, while the EPS is projected at 4.24. These estimates reflect recent revisions, with revenue estimates revised downward by -0.26% and EPS estimates revised downward by -0.41% over the past three months, indicating analyst expectation in the company's performance.

The correlation between NVO's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised downward by -0.26%, while EPS estimates moved revised downward by -0.41%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, NVO's stock price typically moves by 6% in the 10 days before its earnings and 5.13% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 4.24 and revenue of 76.16B.

The earnings call summary indicates a mixed outlook. While there are positive elements such as a 16% increase in Wegovy sales and optimistic guidance for Wegovy pill demand, there are also concerns about declining U.S. sales and significant restructuring costs. The Q&A reveals uncertainties in volume uplift and market dynamics, particularly in the obesity sector. These mixed signals, along with stable but not exceptional financial metrics, suggest a neutral sentiment, expecting minimal stock price movement in the short term.